| Inbound Relationships | 
Type | 
Active | 
Source | 
Characteristic | 
Refinability | 
Group | 
| Ear drops solution | 
Is a | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Ear spray solution | 
Is a | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely chloramphenicol 5 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely desonide 500 microgram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Ciprofloxacin 2 mg/mL ear solution | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| ättiksyra, koncentrerad, 2 %, lösning | 
Has manufactured dose form | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| fenazon 5,4 vikt/volymprocent + bensokain 1,442 vikt/volymprocent, lösning | 
Has manufactured dose form | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| ciprofloxacin 0,2 % + hydrokortison 1 %, lösning, för användning i öra | 
Has manufactured dose form | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Benzocaine 200 mg/mL cutaneous solution | 
Has manufactured dose form | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| trietanolaminpolypeptidoleatkondensat 10 %, lösning | 
Has manufactured dose form | 
False | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) | 
Has manufactured dose form | 
True | 
Ear solution | 
Inferred relationship | 
Some | 
  |